Pelvic Mesh Lawsuits Mount Against Boston Scientific

The list of lawsuits and complaints over the negative adverse effects of pelvic mesh just seems to be getting longer and longer.

Another mesh maker, Boston Scientific, has joined makers such as Johnson & Johnson, C.R. Bard, Covidien and others in reporting that their company is sharing in all of the negative attention, as they have 2,500 pending lawsuits claiming injury from pelvic mesh.

In a regulatory filing, Boston Scientific says most of the plaintiffs are suing over fraud, breach of warranty or failure to warn, and that many of the cases have been consolidated into a single federal court in West Virginia and in Massachusetts state court. Furthermore, the company found out in October that it is the subject of a civil investigation into its sales practices for the implants, led by the California attorney general and other state offices.

Boston Scientific has also just reported that its Women’s Health business declined 11% worldwide in the third quarter. According to a transcript of Boston Scientific’s third quarter earnings conference call, the decline in its Women’s Health business was fueled, in part, by concerns surrounding the use of vaginal mesh products for pelvic organ prolapse repair.

Pelvic Mesh Lawsuits Continue

In July 2011, the U.S. Food & Drug Administration (FDA) warned that there had been a five-fold increase in reports of serious complications associated with the use of pelvic mesh. The FDA also modified its previous position on the frequency of such complications, stating in the alert that vaginal mesh injuries associated with pelvic organ prolapse repair were not rare. Since then, a growing number of pelvic mesh lawsuits have been filed by women throughout the country who allege they sustained serious, painful and life-changing injuries following implantation of vaginal mesh to treat pelvic organ prolapse and stress urinary incontinence.

On November 2, 2012, Judge Joseph R. Goodwin, who is overseeing federal vaginal mesh lawsuits, issued Pretrial Order #22, Submission of Bellwether Plan. Among other things, Judge Goodwin ordered the parties to determine if bellwether trials in three vaginal mesh litigations should begin in 2013.

The first federal vaginal mesh bellwether trial, involving pelvic mesh products manufactured by C.R. Bard, is scheduled to begin on February 5, 2013 in the Southern District of West Virginia.

, , , , ,

No comments yet.

Leave a Reply

  • This field is for validation purposes and should be left unchanged.
Latest Drug Injury News

Paxil Possibly Linked To Breast Cancer Risk

Cancer researchers from the City of Hope National Medical Center announced a possible link between Paxil and breast cancer. Research focused on Paxil’s estrogen effect Researchers found that Paxil has a weak estrogen effect that could increase women’s breast cancer risks. According to lead author and chairman of City of Hope’s Department of Cancer and […]

Big Pharma under Fire for Kickbacks to Docs

Trust and honesty are the cornerstones to a doctor-patient relationship. With so many doctors receiving financial incentives to use certain medications or medical devices, patients need to know if money drives the decision making process. Doctors are required to disclose potential financial conflicts to each other at conferences, but there currently is no law forcing […]

Dietary Supplements Damage Liver

A recent study revealed a significant increase in liver damage related to dietary supplements. The study, conducted by a national network of liver specialists, found a 13% increase in serious liver damage over a 10 year span. Some of these patients required liver transplants and some have even died due to liver failure. Authors of […]

FDA Advisory Committee Supports Approval of Gilead’s HIV Reducing Drug

The pharmaceutical industry may be on the verge of one of the greatest breakthrough’s that this generation has ever seen.

U.S. Health Regulators Issue New Restrictions For Gilenya, Novartis AG’s’ Multiple Sclerosis Pill

In December 2011, the FDA issued a Drug Safety Communication concerning a patient with multiple sclerosis (MS) who died within 24 hours of taking the first dose of Gilenya (fingolimod).

Latest Medical Device Injury News

Report Raises Concerns Over Heart Defibrillator Leads

The Food and Drug Administration (FDA) has just announced that they received a report that a St. Jude Durata cardiac defibrillator lead conductor became externalized; meaning the wire carrying electricity from the heart defibrillator to the heart was exposed through its insulation, a potentially dangerous and life-threatening defect.

HeartSine Class 1 Defibrillator Recall

HeartSine sent out a letter to customers in September, warning that the defibrillators may intermittently turn on and off, eventually depleting the battery.

FDA Medical Device Approval Based On Little Evidence

More than half of the high-risk cardiovascular devices approved in the past decade had no supporting active control data.

St. Jude Medical Gets FDA Warning

St. Jude Medical Inc. said it received a FDA warning about manufacturing and quality-control problems at its Sylmar, California, plant.

Hospira Still Facing Manufacturing And Regulatory Issues

Hospira has sent out 11 device notifications so far in 2013, including recall and device corrections. The company also said it sent notices to customers about some of its infusion pumps that had to either be recalled, fixed or adjusted.